Desentum Oy

Private

EspooHealthcare & Life Scienceshttps://desentum.fi/

Last Round

VC Round

Apr 27, 2026

Total Funding Raised

$28.9M

Company Overview

Desentum Oy is a clinical-stage biopharmaceutical company that develops novel allergen immunotherapy products designed to switch the immune system's response to allergens from hypersensitivity to tolerance.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Clinical Trials, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

allergen immunotherapyallergy vaccinerecombinant hypoallergensallergy shotsbiopharmaceuticalimmune toleranceclinical-stage biotechbirch pollen allergyfood allergy treatmentimmunotherapy platformdrug developmentbiotech startupallergy immunotherapyAIT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Desentum Oy Comps

Public and private peers based on sector, stage, and business model.

Desentum Oy comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Desentum Oy Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Apr 27, 2026
Series C	Feb 20, 2024
Series A	Jan 21, 2022
VC Round	Nov 1, 2019
Grant	Oct 29, 2018
Crowdfunding	Nov 29, 2017

View all Funding Rounds

Desentum Oy Investors

Notable investors and investment history

Desentum Oy investors
Investor	Rounds
Cascara Ventures	Series A
VTT Holding	Series A
European Innovation Council Fund	Grant
Springvest	VC Round, Series A, Series C

View all Investors

Desentum Oy Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Desentum Oy Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Desentum Oy's valuation, stock price, and market status.

Firmographic Details

HeadquartersEspoo

Employee Range12

Year Founded2011

Last FundingApr 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.